Background/Aims: Skeletal maturation is considered a reliable variable in evaluating the ‘tempo’ of growth. It is important in the diagnosis of endocrinological diseases, in chronic diseases, in hormonal therapy follow-up and in computing height prediction for prognostic and therapeutic purposes. It is also used when chronological age is not available for minors without known birth dates. There are different methods to evaluate skeletal maturation and height prediction. The Tanner-Whitehouse (TW) method 2 (TW2) has been considered to be the most useful method so far, and has recently been updated with modified height prediction equations (TW2-Mark II). TW3 is the newest method. The aim of this study is to evaluate whether TW3 is more accurate in the assessment of height prediction than TW2-Mark II in a sample of healthy north Italian subjects. Methods: Anthropometrical data were collected as part of a survey in 1977–1978 in Turin. The sample involved 1,384 healthy children. The children, now adults, have been traced and recalled to measure their final height in order to test height prediction reliability. At present, we have collected 118 adult heights. Results: According to the TW2 method 40% of the males had a height prediction error larger than ± residual SD (4.1 cm), and with TW3 this was 32.9%. The female height prediction error with TW2 was larger than ± residual SD (3.6 cm) in 29.2% of girls, and the same value was found with TW3. Conclusion: According to our preliminary data, TW3 does not represent any real progress.

Keywords:
Adult height prediction, Tanner-Whitehouse method 2 and 3, Skeletal maturation
1.
Frisch RE, Nagel JS: Prediction of adult height of girls from age of menarche and height at menarche. J Paediatr 1974;85:838–841.
2.
Marshall WA: Interrelationship of skeletal maturation, sexual development and somatic growth in man. Ann Hum Biol 1974;1:29–40.
3.
Tanner JM: Foetus into Man. Darien, Open Books, 1978.
4.
Benso L, Vannelli S, Pastorin L, Benso A, Milani S: Variation of bone age progression in healthy children. Acta Paediatr Suppl 1997;423:109–112.
5.
Bull RK, Edwards PD, Kemp PM, Fry S, Hughes IA: Bone age assessment: a large comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods. Arch Dis Child 1999;81:172–173.
6.
Pastorin L, Stasiowska B, Rota A, Benso L: La maturazione scheletrica nella popolazione scolastica di Torino. Confronto tra il metodo TW2 e quello di Greulich e Pyle. Minerva Pediatr 1982;29:2343–2344.
7.
Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H: Assessment of Skeletal Maturity and Prediction of Adult Height [TW2 Method]. London, Academic Press, 1983.
8.
Tanner JM, Healy MJR, Goldstein H, Cameron N: Assessment of Skeletal Maturity and Prediction of Adult Height [TW3 Method]. London, Harcourt, 2001.
9.
Benso L, Giacchino M, Corradetti R, Pastorin L, Longo C, Stasiowska B, Rosa Brunet M, Passone C, Rota A, Anglesio M, Nigro N: Aspetti metodologici di un programma antropometrico. Minerva Endocrinol 1977;4:227–234.
10.
Benso L, Corradetti L, Fabio MT, Ferrari G, Nigro M, Pastorin L, Rota A, Passone C, Stasiowska B: Statura e peso degli scolari elementari torinesi nell’anno 1976–77. Nota I: maschi. Minerva Pediatr 1980;32:75–76.
11.
Cameron N: The Methods of Auxological Anthropometry. Human Growth. A Comprehensive Treatise. New York, Plenum Press, 1986, vol 3.
12.
Gilli G, Hoppe W, Benso L: TW3 Method for prediction of adult height in children with congenital renal diseases. 12th Int Congr Endocrinology, Lisbon, 2004, pp 1419–1423.
© 2007 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.